Drugs / PLAZINEMDOR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04306146 | Feb 2020 → Sep 2021 | schizophrenia | Cadent Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PLAZINEMDOR | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650459 ↗ |
| Known as | CAD-9303 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04306146 ↗ |